Allay Therapeutics

company

About

Allay Therapeutics offers analgesic products for post-surgical pain management and recuperation.

Details

Last Funding Type
Series C
Industries
Biotechnology,Health Care,Medical,Therapeutics
Founded date
Jan 1, 2017
Number Of Employee
11 - 50
Operating Status
Active
Legal Name
Allay Therapeutics, Inc.

Allay Therapeutics offers analgesic products for post-surgical pain management and recuperation. The company was founded in 2017 and is headquartered in Menlo Park, California, United States.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
4
$92M
Allay Therapeutics has raised a total of $92M in funding over 2 rounds. Their latest funding was raised on Dec 13, 2022 from a Series C round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Dec 13, 2022 Series C 1 Detail
Sep 15, 2021 Series C $60M 8 Arboretum Ventures Detail
Jan 1, 2019 Series B $25M 3 New Enterprise Associates Detail
Jan 9, 2017 Series A $7M 1 Lightstone Ventures Detail

Investors

Number of Lead Investors
Number of Investors
3
10
Allay Therapeutics is funded by 10 investors. Arboretum Ventures and Evonik Venture Capital are the most recent investors.
Investor Name Lead Investor Funding Round
Arboretum Ventures Yes Series C
Evonik Venture Capital Series C
Brandon Capital Partners Series C
New Enterprise Associates Series C
Pavilion Capital Series C
Temasek Holdings Series C
Vertex Growth Fund Series C
Vertex Ventures HC Series C
WTT Investment Series C
Lightstone Ventures Series B

Employee Profiles

Number of Employee Profiles
12
Allay Therapeutics has 12 current employee profiles, including Board member Josh Makower
Board member
Executive
Board member
Board member
Board member